Cargando…
Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789896/ https://www.ncbi.nlm.nih.gov/pubmed/35078992 http://dx.doi.org/10.1038/s41419-022-04543-z |
_version_ | 1784639878805323776 |
---|---|
author | Lin, Shu Yu, Lifeng Song, Xinyue Bi, Jia Jiang, Longyang Wang, Yan He, Miao Xiao, Qinghuan Sun, Mingli Olopade, Olufunmilayo I. Zhao, Lin Wei, Minjie |
author_facet | Lin, Shu Yu, Lifeng Song, Xinyue Bi, Jia Jiang, Longyang Wang, Yan He, Miao Xiao, Qinghuan Sun, Mingli Olopade, Olufunmilayo I. Zhao, Lin Wei, Minjie |
author_sort | Lin, Shu |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8789896 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-87898962022-02-07 Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response Lin, Shu Yu, Lifeng Song, Xinyue Bi, Jia Jiang, Longyang Wang, Yan He, Miao Xiao, Qinghuan Sun, Mingli Olopade, Olufunmilayo I. Zhao, Lin Wei, Minjie Cell Death Dis Correction Nature Publishing Group UK 2022-01-25 /pmc/articles/PMC8789896/ /pubmed/35078992 http://dx.doi.org/10.1038/s41419-022-04543-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correction Lin, Shu Yu, Lifeng Song, Xinyue Bi, Jia Jiang, Longyang Wang, Yan He, Miao Xiao, Qinghuan Sun, Mingli Olopade, Olufunmilayo I. Zhao, Lin Wei, Minjie Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response |
title | Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response |
title_full | Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response |
title_fullStr | Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response |
title_full_unstemmed | Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response |
title_short | Correction: Intrinsic adriamycin resistance in p53-mutated breast cancer is related to the miR-30c/FANCF/REV1-mediated DNA damage response |
title_sort | correction: intrinsic adriamycin resistance in p53-mutated breast cancer is related to the mir-30c/fancf/rev1-mediated dna damage response |
topic | Correction |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8789896/ https://www.ncbi.nlm.nih.gov/pubmed/35078992 http://dx.doi.org/10.1038/s41419-022-04543-z |
work_keys_str_mv | AT linshu correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT yulifeng correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT songxinyue correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT bijia correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT jianglongyang correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT wangyan correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT hemiao correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT xiaoqinghuan correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT sunmingli correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT olopadeolufunmilayoi correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT zhaolin correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse AT weiminjie correctionintrinsicadriamycinresistanceinp53mutatedbreastcancerisrelatedtothemir30cfancfrev1mediateddnadamageresponse |